47
https://pubmed.ncbi.nlm.nih.gov/38091574
In diffuse large B-cell lymphoma patients who can’t access CAR-T cell therapy, autologous hematopoietic cell transplantation after complete remission with bridging chemotherapy may lead to better outcomes.